Renal Denervation Using the Vessix Renal Denervation System for the Treatment of Hypertension (REDUCE HTN:REINFORCE)

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 7, 2017

Study Completion Date

August 2, 2019

Conditions
Hypertension
Interventions
DEVICE

Renal Denervation (Vessix)

Percutaneous renal denervation using the Vessix Reduce™ Catheter and Vessix™ Generator

DEVICE

Renal Angiography

Percutaneous renal angiography

Trial Locations (12)

10032

Columbia University Medical Center, New York

19141

Albert Einstein Medical Center, Philadelphia

21201

University of Maryland, Baltimore

33140

Mount Sinai Medical Center, Miami Beach

35211

Cardiology, PC, Birmingham

37660

Wellmont CVA Heart Institute, Kingsport

54401

Aspirus Heart and Vascular Institute, Wausau

70360

Cardiovascular Institute of the South, Houma

75006

Dallas Medical Center, Dallas

75231

Cardiovascular Research Institute of Dallas, Dallas

90048

Cedars - Sinai Medical Center, Los Angeles

02111

Tufts Medical Center, Boston

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY